Utility of standardized histological classification in the management of acute rejection

Transplantation

Volumn 65, Issue 3, 1998, Pages 376-380

  Gaber, Lillian W ^a   Moore, Linda W ^a   Gaber, A Osama ^a   First, M Roy ^b   Guttmann, Ronald D ^c   Pouletty, Philippe ^d   Schroeder, Timothy J ^b   Soulillou, Jean Paul ^e  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d GENZYME CORPORATION   (United States)

^e SangStat Atlantique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; GRAFT REJECTION; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; QUESTIONNAIRES; TIME FACTORS;

EID: 0032519669     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802150-00013     Document Type: Article

References (11)

1. Finkelstein FO, Siegel NJ, Bastl C, Forrest JN Jr, Kashgarian M. Kidney transplant biopsies in the diagnosis and management of acute rejection reactions. Kidney Int 1976; 10: 171.
2. Hsu AC, Arbus GS, Noriega E, Huber J. Renal allograft biopsy: a satisfactory adjunct for predicting renal function after graft rejection. Clin Nephrol 1976; 5: 260.
3. Kiaer H, Hansen HE, Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 1980; 13: 58.
4. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
5. Marcussen N, Olsen TS, Benediktsson H, Racusen L, Solez K. Reproducibility of the Banff Classification of renal allograft pathology. Transplantation 1995; 60: 1083.
6. Wiener Y, Nakhleh RE, Kupin M, et al. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection. Transplant Proc 1995; 27: 1014.
7. Gaber LW, Schroeder TJ, Moore LW, Shokouh-Amiri MH, Gaber AO. The correlation of Banff scoring with reversibility of first and recurrent rejection episodes. Transplantation 1996; 61: 1711.
8. Dooper MM, Hoitsma AJ, Koene RAP, Bogman MJJT. Evaluation of the Banff criteria for the histological diagnosis of rejection in renal allograft biopsies. Transplant Proc 1995; 27: 1005.
9. Tesi RL, Elkhammas EA, Henry ML, Ferguson RM. OKT3 for primary therapy of the first rejection episode in kidney transplants. Transplantation 1993; 55: 1023.
10. Schroeder TJ, Weiss MA, Smith RD, et al. The use of OKT3 in the treatment of acute vascular rejection. Transplant Proc 1991; 23: 1043.
11. Carrier M, Jenicek M, Pelletier LC. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis. Transplant Proc 1992; 24: 2586.